RelayPro Thoracic Stent-Graft System 28-M4-42-195-42URecalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of RelayPro Thoracic Stent-Graft System (127)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00843576149953), received between Jan 28, 2026 and Jan 28, 2026 — classified as 1 injury.
The most frequently reported specific device problem is “Lack of Effect” (1 report).
2 other recalls cover devices cleared under the same FDA submission (P200045); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Lack of Effect1
Patient problems
- Vascular Dissection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJan 28, 2026Lack of Effect
"DISSECTION (RETROGRADE TYPE A DISSECTION ORIGINATING FROM THE TIP OF THE STENT GRAFT FABRIC): ON (B)(6) 2025, A TWO-DEBRANCHING TEVAR WAS PERFORMED. FIRST, A RELAY PRO NBS (28-N4-32-209-28U) WAS PLACED DISTALLY, FOLLOWED BY THE RELAY PRO BS (28-M4-42-195-42U) PLACED PROXIMALLY. THE LEFT SUBCLAVIAN ARTERY AND LEFT COMMON CAROTID ARTERY WERE EMBOLIZED WITH COILS, AND THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITHOUT ANY VISIBLE LEAK. POSTOPERATIVELY, AN ABNORMAL INFLAMMATORY RESPONSE PERSISTED, SO A CONTRAST-ENHANCED CT SCAN WAS PERFORMED ON (B)(6), WHICH CONFIRMED RETROGRADE TYPE A AORTIC DISSECTION. AN EMERGENCY OPERATION WAS PLANNED TO PERFORM ASCENDING AORTIC REPLACEMENT AND LEFT BRACHIOCEPHALIC ARTERIAL RECONSTRUCTION. PHYSICIAN'S COMMENT: IN THIS CASE, A TWO-DEBRANCHING TEVAR WAS PERFORMED FOR TYPE B AORTIC DISSECTION. SUBSEQUENTLY, R-TAD DEVELOPED. WHILE THE PHYSICIAN BELIEVES THIS WAS THE ONLY AVAILABLE TREATMENT OPTION, IT MAY HAVE BEEN PREFERABLE TO USE A DEVICE ONE SIZE SMALLER. CAUSALITY BETWEEN THE PRODUCT AND THE EVENT CANNOT BE DENIED AS THE DISSECTION ORIGINATED FROM THE TIP OF THE STENT-GRAFT FABRIC. OPERATION TYPE: TWO-DEBRANCHING TEVAR BLOOD LOSS: THERE WAS BLOOD L
Patient problems: Vascular Dissection
MAUDE report 24202784 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P200045. One submission often covers many models, so check the product and lot details in each record.
- Z-2160-2026 · Apr 22, 2026 · Open, ClassifiedRelayPro Thoracic Stent-Graft System (various sizes) Reference numbers: 28-N4-32-104-32U 28-N4-32-164-28U 28-N4-32-164-32U 28-N4-32-209-28U 28-N4-32-209-32U 28-N4-32-259-32U 28-N4-
- Z-1383-2024 · Feb 22, 2024 · CompletedRELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and patient tracking card, sterile: (a) Part number 28-M4-34-100-34U; (b) Part number 2
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page